Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Amarin, American Regent, Ascentage, Astrazeneca, Beigene, Biophytis, Canbridge, Cocrystal, Daiichi Sankyo, Eddingpharm, Gilead, Hutchmed, Innovent, Inventiva, Novavax, Sino, SK, Takeda.